What is RecoMed?
RecoMed operates as a comprehensive online healthcare booking platform, primarily serving the South African market. It facilitates seamless connections between patients and a diverse network of healthcare professionals, encompassing general practitioners, dentists, and specialists. The platform's suite of services is designed to elevate patient convenience and accessibility, offering features such as virtual consultations, efficient medicine delivery, and streamlined appointment management. Beyond patient-centric solutions, RecoMed also empowers healthcare practitioners by providing tools to optimize practice efficiency and boost patient engagement. With a substantial network of over 3000 practitioners and a monthly volume of 100,000 online bookings, RecoMed is instrumental in modernizing the healthcare experience for all stakeholders.
How much funding has RecoMed raised?
RecoMed has raised a total of $324K across 1 funding round:
Unspecified
$324K
Unspecified (2017): $324K with participation from HAVAIC and Growth Grid Venture Capital Partners
Key Investors in RecoMed
HAVAIC
HAVAÍC is a venture capital firm based in Cape Town that specializes in early-stage, high-growth technology businesses with impactful solutions, focusing on local investments with global prospects in Africa. They provide strategic support and capital raising expertise to maximize impact and returns for innovative platforms.
Growth Grid Venture Capital Partners
Growth Grid Venture Capital Partners is a South African venture capital company established in 2017, specializing in deal origination, capital raising, due diligence, entrepreneurship, and market access for growing businesses.
What's next for RecoMed?
With the recent influx of capital, RecoMed is strategically positioned to accelerate its growth and solidify its market leadership. The 'large-scale late-stage funding' context suggests a focus on scaling operations, potentially through geographic expansion within South Africa or into new African markets. Further investment in technology development is anticipated, possibly enhancing its virtual consultation capabilities, AI-driven appointment scheduling, or data analytics for healthcare providers. Strategic partnerships with larger healthcare institutions or pharmaceutical companies may also be on the horizon, aiming to integrate RecoMed's platform more deeply into the healthcare ecosystem. The company's trajectory indicates a strong emphasis on operational efficiency and expanding its value proposition to both patients and practitioners, reinforcing its role as a key player in the digital health transformation.
See full RecoMed company page
